Co-Diagnostics Inc
(CODX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 893 | 950 | 3,535 | 999 | N/A |
| Receivables | 131 | 13 | N/A | 3 | N/A |
| Inventories | 197 | 18 | 9 | N/A | N/A |
| TOTAL | $1,584 | $1,052 | $4,452 | $1,208 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 197 | 156 | 166 | 87 | N/A |
| Investments And Advances | 434 | 345 | 45 | 0 | 0 |
| TOTAL | $631 | $501 | $211 | $87 | $N/A |
| Total Assets | $2,215 | $1,553 | $4,662 | $1,296 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6 | 149 | 41 | 105 | 0 |
| Accrued Expenses | 321 | 294 | 577 | 791 | N/A |
| TOTAL | $328 | $2,352 | $628 | $3,845 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 445 | N/A |
| Deferred Revenues | 1 | N/A | 11 | N/A | N/A |
| Other Non-Current Liabilities | 150 | 260 | 0 | 0 | 0 |
| TOTAL | $150 | $260 | $184 | $445 | $N/A |
| Total Liabilities | $478 | $2,612 | $812 | $4,290 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 914 | 567 | 410 | N/A | N/A |
| Common Shares | 17 | 13 | 12 | 10 | N/A |
| Retained earnings | -24,968 | -18,694 | -12,422 | -5,463 | N/A |
| TOTAL | $1,737 | $-1,059 | $3,851 | $-2,995 | $N/A |
| Total Liabilities And Equity | $2,215 | $1,553 | $4,662 | $1,296 | $0 |